ArticleJournal of cancer research and clinical oncology2024

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade.

Miriam Mengoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.